EGFR inhibitors (University of New Mexico/Science & Technology Corporation @ UNM)

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameEGFR inhibitors (University of New Mexico/Science & Technology Corporation @ UNM)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase inhibitorsEpidermal growth factor receptor erbB1 inhibitors
TargetsMitogen-activated protein kinaseEpidermal growth factor receptor erbB1
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of New Mexico
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStc.UnmThe University Of New Mexico
Active IndicationsN/A
Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A